Letter to the Editor
In the past, the UK MDA independently commissioned, funded, and published freely available "blue cover report" evaluations of the performance of all blood glucose meter systems entering the UK market for inclusion on the NHS DT. These provided independent, impartial, comprehensive evaluation studies undertaken in a standardized manner using protocols agreed with manufacturers. Although manufacturers were not involved in practical aspects of undertaking such independent evaluations, the manufacturers were given an opportunity to input by comment on the protocol, providing BGMS and to comment on the report and interpretation of results. These features, which are not present in many current peer-reviewed published evaluation studies, improved quality and ensured these independent studies and publications were clearly seen as balanced, valid, high-quality, and impartial.
Funding of accuracy studies by independent bodies is however currently very infrequent, and virtually all evaluation studies and publications are funded by industry. While appropriate independent evaluation of accuracy is essential and welcomed, correct evaluation is complex. In the rare occasions when high-quality independent evaluations take place, while not being directly involved in practical aspects of the studies, manufacturers should be provided with the opportunity to input by commenting on the protocol, the systems/strips used and their handling, and allowed to include summary interpretive comments.
The publication by Vanterpool 1 discussed here warrants discussion: When taken in combination, all the points above show the study unfortunately failing to demonstrate sufficient safeguards to ensure it is truly independent and impartial.
